FdaApplication
BLA 761113
Identifiers
- fda_app_no: BLA761113
Properties
| Property | Value |
|---|---|
| applicant_name | Sanofi-Aventis U.S. LLC |
| application_type | BLA |
| approval_date | 2020-03-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SARCLISA | ISATUXIMAB-IRFC | 100MG/5ML (20MG/ML) | Injection |
| SARCLISA | ISATUXIMAB-IRFC | 500MG/25ML (20MG/ML) | Injection |
2 products